论文部分内容阅读
近几年来.国内外研究资料显示:对2型糖尿病患者早期进行胰岛素强化治疗,短期内将血糖控制在正常范围内,有利于保护残存的β细胞功能,可延缓糖尿病及其并发症的发生发展〔1,2〕。控制好血糖,减少糖尿病并发症的发生,同时又避免发生严重低血糖,一直是研究热点。研究旨在初步分析初诊2型糖尿病4种胰岛素强化治疗方案的短期血糖控制效果及胰岛β细胞功能恢复情况,初步比较2型糖尿病4种胰岛素强化治疗方案的经济负担及其治疗效果。
In recent years, domestic and foreign research data show that early treatment of type 2 diabetes patients with insulin intensified short-term blood glucose control in the normal range, is conducive to the protection of residual β-cell function, can delay the occurrence of diabetes and its complications [1,2]. Control of blood sugar, reduce the incidence of diabetic complications, while avoiding the occurrence of severe hypoglycemia, has been a research hotspot. The aim of this study was to initially analyze the short-term glycemic control and the recovery of pancreatic β-cell function in 4 insulin-intensive treatment regimens of newly diagnosed type 2 diabetes mellitus and to compare the economic burden and therapeutic effect of 4 intensive insulin regimens for type 2 diabetes mellitus.